We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...
18hon MSN
Central Board of Secondary Education (CBSE) has laid out clear guidelines for Class 10 and 12 students, specifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback